Published in Gene Therapy Weekly, January 24th, 2002
Using enhanced green fluorescent protein (EGFP) as a model antigenic protein, BioTransplant researchers have established a preclinical model of immune tolerance for cellular transplants. The data were presented at the 43rd Annual Meeting of the American Society for Hematology (ASH) in Orlando, Florida.
EGFP is commonly used as a reporter protein in gene transfer protocols because it produces a green color and can be seen in cells. When it is linked to a medically important gene, it reports that the gene has been...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.